Overview

Community Based Trial for AMEVIVE®

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety of treating subjects with up to 12 additional doses of alefacept.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Biogen
Treatments:
Alefacept